Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-18 in COVID-19 Pneumonia
NCT04500132Phase 2Completed
- Sponsor
- Enzychem Lifesciences
- Start
- May 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosedipimod in COVID-19 pneumonia, sponsored by Enzychem Lifesciences. Started May 2020; status: completed.
02
Drugs
mosedipimod
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04500132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500132.